99651-37-3

Usage

Uses

Used in Pharmaceutical Industry:
2-Methyl-2H-[1,2,4]triazole-3-carbaldehyde is used as a key intermediate in the synthesis of pharmaceuticals for its ability to form diverse derivatives with potential therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Methyl-2H-[1,2,4]triazole-3-carbaldehyde is utilized as a building block in the development of agrochemicals, contributing to the creation of compounds with pesticidal or herbicidal activities.
Used in Dye Industry:
2-Methyl-2H-[1,2,4]triazole-3-carbaldehyde is employed as a versatile component in the production of dyes, where its capacity to form various derivatives allows for the creation of a wide array of colorants.
Used in Organic Synthesis:
As a reagent in organic synthesis, 2-Methyl-2H-[1,2,4]triazole-3-carbaldehyde is used for the preparation of heterocyclic and biologically active compounds, highlighting its importance in the synthesis of complex organic molecules.
Used in Corrosion Inhibition:
2-Methyl-2H-[1,2,4]triazole-3-carbaldehyde has potential applications in the field of corrosion inhibition, where it may be utilized to develop compounds that protect materials from degradation.
Used in Fragrance Production:
In the fragrance industry, 2-Methyl-2H-[1,2,4]triazole-3-carbaldehyde serves as an intermediate in the production of various scented compounds, adding to the diversity of fragrances available.

Upstream product

• 6086-21-1 1-methyl-1H-1,2,4-triazole 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 169377-67-7 5-(1,3-dioxolan-2-yl)-1-methyl-1,2,4-triazole 
• 1207454-59-8 ethyl 3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-2-phenyl-1,2,3,4-tetrahydroquinoline-5-carboxylate 
• 1207455-88-6 ethyl 7-fluoro-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-2-phenyl-1,2,3,4-tetrahydroquinoline-5-carboxylate 
• 1207454-57-6 ethyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate 
• 1207454-64-5 ethyl 2-(4-((dimethylamino)methyl)phenyl)-7-fluoro-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate 
• 1207454-61-2 ethyl 2-(4-((dimethylamino)methyl)phenyl)-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate 
• 1207454-68-9 ethyl 2-(4-fluorophenyl)-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate 
• 1322616-34-1 (Z)-6-fluoro-3-((1-methyl-1H-1,2,4-triazol-5-yl)methylene)-4-nitroisobenzofuran-1(3H)-one 

Relevant academic research and scientific papers

DoE Optimization Empowers the Automated Preparation of Enantiomerically Pure [18F]Talazoparib and its in Vivo Evaluation as a PARP Radiotracer

Given the clinical potential of poly(ADP-ribose) polymerases (PARP) imaging for the detection and stratification of various cancers, the development of novel PARP imaging probes with improved pharmacological profiles over established PARP imaging agents i

Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof

Substitutued heterocyclylisoquinolinium salts, pharmaceutical compositions containing them and methods for the treatment or prevention of neurodegenerative disorders or neurotoxic injuries utilizing them.